Phage Therapy: What Have We Learned?

Phage Therapy: What Have We Learned?

In this article we explain how current events in the field of phage therapy may positively influence its future development. We discuss the shift in position of the authorities, academia, media, non-governmental organizations, regulatory agencies, patients, and doctors which could enable further adv...

Full description

Bibliographic Details
Main Authors:	Andrzej Górski, Ryszard Międzybrodzki, Małgorzata Łobocka, Aleksandra Głowacka-Rutkowska, Agnieszka Bednarek, Jan Borysowski, Ewa Jończyk-Matysiak, Marzanna Łusiak-Szelachowska, Beata Weber-Dąbrowska, Natalia Bagińska, Sławomir Letkiewicz, Krystyna Dąbrowska, Jacques Scheres
Format:	Article
Language:	English
Published:	MDPI AG 2018-05-01
Series:	Viruses
Subjects:	phage therapy experimental therapy phage cocktails anti-phage antibodies prophage immunomodulation
Online Access:	http://www.mdpi.com/1999-4915/10/6/288

Similar Items

Phage Therapy: Beyond Antibacterial Action
by: Andrzej Górski, et al.
Published: (2018-05-01)

Phage Therapy in Prostatitis: Recent Prospects
by: Andrzej Górski, et al.
Published: (2018-06-01)

The Potential of Phage Therapy in Sepsis
by: Andrzej Górski, et al.
Published: (2017-12-01)

Phage Therapy in Poland – a Centennial Journey to the First Ethically Approved Treatment Facility in Europe
by: Maciej Żaczek, et al.
Published: (2020-06-01)

Do Anti-Phage Antibodies Persist after Phage Therapy? A Preliminary Report
by: Marzanna Łusiak-Szelachowska, et al.
Published: (2022-10-01)

“Phage Transplantation in Allotransplantation”: Possible Treatment in Graft-Versus-Host Disease?
by: Andrzej Górski, et al.
Published: (2018-04-01)

Antibody production in response to staphylococcal MS-1 phage cocktail in patients undergoing phage therapy
by: Maciej Żaczek, et al.
Published: (2016-10-01)

Perspectives of Phage Therapy in Non-bacterial Infections
by: Andrzej Górski, et al.
Published: (2019-01-01)

Low Immunogenicity of Intravesical Phage Therapy for Urogenitary Tract Infections
by: Sławomir Letkiewicz, et al.
Published: (2021-05-01)

A Thorough Synthesis of Phage Therapy Unit Activity in Poland—Its History, Milestones and International Recognition
by: Maciej Żaczek, et al.
Published: (2022-05-01)

Potential for Phages in the Treatment of Bacterial Sexually Transmitted Infections
by: Kathryn Cater, et al.
Published: (2021-08-01)

Bacteriophage Procurement for Therapeutic Purposes
by: Beata Weber-Dąbrowska, et al.
Published: (2016-08-01)

Comparison of bacterial suppression by phage cocktails, dual‐receptor generalists, and coevolutionarily trained phages
by: Joshua M. Borin, et al.
Published: (2023-01-01)

Use of a Regression Model to Study Host-Genomic Determinants of Phage Susceptibility in MRSA
by: Henrike Zschach, et al.
Published: (2018-01-01)

Editorial: Advances in Phage Therapy: Present Challenges and Future Perspectives
by: Petar Knezevic, et al.
Published: (2021-06-01)

Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far
by: Marzanna Łusiak-Szelachowska, et al.
Published: (2022-03-01)

Phage Therapy: Combating Infections with Potential for Evolving from Merely a Treatment for Complications to Targeting Diseases
by: Andrzej Gorski, et al.
Published: (2016-09-01)

Metagenomic Analysis of Therapeutic PYO Phage Cocktails from 1997 to 2014
by: Julia Villarroel, et al.
Published: (2017-11-01)

Compounding <i>Achromobacter</i> Phages for Therapeutic Applications
by: Ana Georgina Cobián Güemes, et al.
Published: (2023-07-01)

Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics
by: Ewa Jończyk-Matysiak, et al.
Published: (2017-06-01)

The Citizen Phage Library: Rapid Isolation of Phages for the Treatment of Antibiotic Resistant Infections in the UK
by: Julie Fletcher, et al.
Published: (2024-01-01)

Bacteriophages in the gastrointestinal tract and their implications
by: Marzanna Łusiak-Szelachowska, et al.
Published: (2017-08-01)

Defeating Antibiotic- and Phage-Resistant Enterococcus faecalis Using a Phage Cocktail in Vitro and in a Clot Model
by: Leron Khalifa, et al.
Published: (2018-02-01)

Phage Therapy: Towards a Successful Clinical Trial
by: Andrzej Górski, et al.
Published: (2020-11-01)

A3R Phage and Staphylococcus aureus Lysate Do Not Induce Neutrophil Degranulation
by: Jan Borysowski, et al.
Published: (2017-02-01)

Fitness Trade-Offs in Phage Cocktail-Resistant Salmonella enterica Serovar Enteritidis Results in Increased Antibiotic Susceptibility and Reduced Virulence
by: Dongyang Gao, et al.
Published: (2022-10-01)

A Novel Phage Cocktail Therapy of the Urinary Tract Infection in a Mouse Model
by: B Mijbel Ali, et al.
Published: (2021-11-01)

The Battle between Bacteria and Bacteriophages: A Conundrum to Their Immune System
by: Addisu D. Teklemariam, et al.
Published: (2023-02-01)

Introducing a Novel, Broad Host Range Temperate Phage Family Infecting Rhizobium leguminosarum and Beyond
by: Sam Ford, et al.
Published: (2021-11-01)

Perspectives of Phage–Eukaryotic Cell Interactions to Control Epstein–Barr Virus Infections
by: Andrzej Górski, et al.
Published: (2018-04-01)

Interactions of Bacteriophages with Animal and Human Organisms—Safety Issues in the Light of Phage Therapy
by: Magdalena Podlacha, et al.
Published: (2021-08-01)

On-demand isolation of bacteriophages against drug-resistant bacteria for personalized phage therapy
by: Sari eMattila, et al.
Published: (2015-11-01)

Sepsis, Phages, and COVID-19
by: Andrzej Górski, et al.
Published: (2020-10-01)

How Interest in Phages Has Bloomed into a Leading Medical Research Activity in Poland
by: Maciej Żaczek, et al.
Published: (2022-11-01)

Deploying Viruses against Phytobacteria: Potential Use of Phage Cocktails as a Multifaceted Approach to Combat Resistant Bacterial Plant Pathogens
by: Tahir Farooq, et al.
Published: (2022-01-01)

In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success
by: Tea Glonti, et al.
Published: (2022-07-01)

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains
by: Christine Rohde, et al.
Published: (2018-04-01)

Development of a Phage Cocktail to Target <i>Salmonella</i> Strains Associated with Swine
by: Anisha M. Thanki, et al.
Published: (2022-01-01)

The Presence of Bacteriophages in the Human Body: Good, Bad or Neutral?
by: Marzanna Łusiak-Szelachowska, et al.
Published: (2020-12-01)

Semi-Solid and Solid Dosage Forms for the Delivery of Phage Therapy to Epithelia
by: Teagan L. Brown, et al.
Published: (2018-02-01)